Duramed
Executive Summary
Generic drug manufacturer nets $ 14 mil. through public offering of 2.3 mil. shares. Proceeds will be used to retire debt, for new product approvals, and as working capital ("The Pink Sheet" July 10, p. 9). Duramed offering is a success in the face of the wide adverse publicity for the generic industry.